Paper41472004
Advances in Infectious Bursal Disease Virus Vaccines-A Review.
Wang W and 13 others. Microorganisms, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Advances in Infectious Bursal Disease Virus Vaccines-A Review. Papers, record 41472004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41472004
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2025J08104 | Natural Science Foundation of Fujian Province | PubMed | ||
| 31660717, 32160824 and 31560706 | National Natural Science Foundation of China | PubMed | ||
| YCBZ2022034 | Innovation Project of Guangxi Graduate Education | PubMed |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20005905 | RNA immunization can protect mice against foot-and-mouth disease virus. | Antiviral Res | 2010 | https://conductscience.org/library/papers/20005905 | PubMed |
| 2 | 19461208 | Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma. | J Vet Sci | 2009 | https://conductscience.org/library/papers/19461208 | PubMed |
| 3 | 14585684 | Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. | Vaccine | 2003 | https://conductscience.org/library/papers/14585684 | PubMed |
| 4 | 16215632 | Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2. | Acta Biochim Biophys Sin (Shanghai) | 2005 | https://conductscience.org/library/papers/16215632 | PubMed |
| 5 | 18680037 | Acute infectious bursal disease in poultry: protection afforded by maternally derived antibodies and interference with live vaccination. | Avian Pathol | 1991 | https://conductscience.org/library/papers/18680037 | PubMed |
| 6 | 25173608 | Molecular epidemiology studies on partial sequences of both genome segments reveal that reassortant infectious bursal disease viruses were dominantly prevalent in southern China during 2000-2012. | Arch Virol | 2014 | https://conductscience.org/library/papers/25173608 | PubMed |
| 7 | 11294672 | Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. | J Infect Dis | 2001 | https://conductscience.org/library/papers/11294672 | PubMed |
| 8 | 11312006 | Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development. | Vaccine | 2001 | https://conductscience.org/library/papers/11312006 | PubMed |
| 9 | 11991992 | Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. | J Virol | 2002 | https://conductscience.org/library/papers/11991992 | PubMed |
| 10 | 15331738 | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. | J Virol | 2004 | https://conductscience.org/library/papers/15331738 | PubMed |
| 11 | 32456830 | Naturally occurring homologous recombination between novel variant infectious bursal disease virus and intermediate vaccine strain. | Vet Microbiol | 2020 | https://conductscience.org/library/papers/32456830 | PubMed |
| 12 | 19559453 | Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins. | Virology | 2009 | https://conductscience.org/library/papers/19559453 | PubMed |
| 13 | 12496961 | Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. | Nat Med | 2003 | https://conductscience.org/library/papers/12496961 | PubMed |
| 14 | 8389805 | Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. | J Gen Virol | 1993 | https://conductscience.org/library/papers/8389805 | PubMed |
| 15 | 6297451 | Characteristics and serologic studies of two serotypes of infectious bursal disease virus in turkeys. | Avian Dis | 1982 | https://conductscience.org/library/papers/6297451 | PubMed |
| 16 | 32898764 | A new generation of vaccines based on alphavirus self-amplifying RNA. | Curr Opin Virol | 2020 | https://conductscience.org/library/papers/32898764 | PubMed |
| 17 | 10329546 | Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. | Virology | 1999 | https://conductscience.org/library/papers/10329546 | PubMed |
| 18 | 34581009 | The emerging naturally reassortant strain of IBDV (genotype A2dB3) having segment A from Chinese novel variant strain and segment B from HLJ 0504-like very virulent strain showed enhanced pathogenicity to three-yellow chickens. | Transbound Emerg Dis | 2022 | https://conductscience.org/library/papers/34581009 | PubMed |
| 19 | 37402042 | The attenuated live vaccine strain W2512 provides protection against novel variant infectious bursal disease virus. | Arch Virol | 2023 | https://conductscience.org/library/papers/37402042 | PubMed |
| 20 | 27916318 | Advances in vaccine research against economically important viral diseases of food animals: Infectious bursal disease virus. | Vet Microbiol | 2017 | https://conductscience.org/library/papers/27916318 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42524070 | Deciphering host-virus interaction networks in ALV infection: an integrative multi-omics perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42524070 | PubMed |
| 42515598 | Infectious Bursal Disease Virus Genotypic Diversity from Poultry in Latin America. | Viruses | 2026 | https://conductscience.org/library/papers/42515598 | PubMed |
| 42436537 | A new recombinant avian metapneumovirus vaccine candidate provides complete protection against the novel variant infectious bursal disease virus in chickens. | Vet Res | 2026 | https://conductscience.org/library/papers/42436537 | PubMed |
| 42220545 | Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220545 | PubMed |
| 42056828 | Development of a recombinant chimeric Newcastle disease virus-vectored vaccine conferring single-dose, triple protection against genotype VII NDV, IBDV, and H9N2 AIV. | Poult Sci | 2026 | https://conductscience.org/library/papers/42056828 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41472004
GET https://conductscience.org/api/papers/v1/41472004/references?page=2